Regulatory Service

Omicron pharma is integrated with a presence of products in worldwide countries. currently exports to over 151 countries and 7 continents globally which include Asia, Africa, North America, South America, Antarctica, Europe, and Australia. With over 1200 International Product Registrations (still expanding) We have a strong base in the Overseas Markets and are enjoying substantial clout at the Omicron Pharma’s Export business has ensured the growth of the company's Formulation business. Our strong commitment of providing quality products is boasted by in-depth industry knowledge, well-qualified team of professionals, as well as hi-tech and advanced infrastructure. Resultantly, creating mutually beneficial associations for all the parties involved. Our 1200 formulation brands are being marketed in multiple countries; of which dossier is in CTD format along with its respective bioequivalence. Our synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with our clients. Omicron pharma’s manufacturing unit has been granted certifications by many regulatory Agencies.

We are pleased to introduce ourselves as Omicron Pharma, Gujarat, India. Omicron Pharma is a well-organized Manufacturer, Supplier and Exporter of a wide range of Pharmaceutical Finished Formulations Products like, Tablets, Capsules, Liquids and Injectable and Active Pharmaceutical Ingredients (API). We produce Pharmaceutical products which are economically manufactured and made available at affordable prices. Being a quality conscious organization, we follow international quality standards. Our company has an extensive manufacturing facility, in-house quality control department, microbiological laboratory and raw material and finished product storage. There is a team of professionals dedicated to new products development and upgrading of existing products on a continuous basis.We have earned accolades from our customers not only in domestic market but also in international market due to our indefatigable and determined commitment towards quality and customer satisfaction. As a result, omicron Pharma has a regular overseas presence in over 86 countries.

OMICRON PHARMA is India’s single largest Contract Research and Manufacturing (CRAMS) organization responsible for manufacturing approximately 11-12 % of all drugs consumed in the country. The organization offers a comprehensive range of services starting from formulation development to market launch all end suite.

• • Contract Research & Manufacturing Services (CRAMS)
• • Formulation & development of Novel Drugs Delivery Systems (N.D.D.S.)
• • Loan License
• • New Formulations with DCGI Approvals
• • Institutional business
• • Technology Transfer
• • Technical collaboration and Joint venture

Domestic front. By maintaining leadership and competitiveness in various therapeutic domains, Omicron pharma's Export business has ensured the growth of the company's Formulation business